Literature DB >> 11138347

Increased gut permeability in juvenile chronic arthritides. A multivariate analysis of the diagnostic parameters.

P Picco1, M Gattorno, N Marchese, S Vignola, M P Sormani, A Barabino, A Buoncompagni.   

Abstract

OBJECTIVE: This study was aimed at evaluating intestinal permeability (IP) in patients with oligoarticular juvenile idiopathic arthritis (o-JIA), spondyloarthropathy (SpA) associated with inflammatory bowel disease (IBD) and other forms of juvenile-onset chronic arthritiis (OIA) using the lactulose/mannitol (L/M) test in comparison with other non-invasive parameters of gut involvement.
METHODS: A series of 26 children affected with o-JIA and 14 with either SpA/IBD or OIA were assessed for IP. The urinary L/M ratio was measured by gas chromatography. The erythrocyte sedimentation rate (ESR), C reactive protein (CRP), and faecal alpha 1 antitrypsin concentrations were also evaluated. Ten o-JIA patients displayed active arthritis while in 16 the disease was under control. Among the OIA patients, 11 were affected with psoriatic arthritis and the remaining 3 with chronic reactive arthritis. 14 patients with SpA-IBD had active synovitis or spine inflammation. 14 eo-pJCA and 22 OIA and SpA-IBD patients, respectively, were receiving NSAID therapy.
RESULTS: The mean L/M ratios for the Spa-IBD (0.07 +/- 0.02, mean +/- SD), OIA (0.05 +/- 0.02) and o-JIA (0.04 +/- 0.02) patients were significantly higher (p < 0.001, p = 0.022 and p = 0.01, respectively) than those found in controls (0.02 +/- 0.01). Logistic regression analysis disclosed a positive correlation between the L/M ratio and the presence of gastrointestinal manifestations (p = 0.011). The type of disease (p = 0.28), the disease activity in the JCA patient group (p = 0.24) and NSAID administration (p = 0.210) did not seem to significantly influence the L/M ratio.
CONCLUSIONS: All of the subtypes of juvenile chronic arthritides that we studied displayed an increased IP. Hence, gut wall inflammation (albeit asymptomatic) may also be present in o-JIA patients. The SpA-IBD patients with gastrointestinal symptoms displayed the highest mean L/M ratio values. The L/M test seemed to correlate with histopathological features of the gut mucosa. The L/M ratio was shown to be a highly sensitive but poorly specific test for predicting gut inflammatory disease compared to other non-invasive screening tests.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11138347

Source DB:  PubMed          Journal:  Clin Exp Rheumatol        ISSN: 0392-856X            Impact factor:   4.473


  19 in total

1.  Serologic Evidence of Gut-driven Systemic Inflammation in Juvenile Idiopathic Arthritis.

Authors:  Lampros Fotis; Nurmohammad Shaikh; Kevin W Baszis; Charles M Samson; Raffi Lev-Tzion; Anthony R French; Phillip I Tarr
Journal:  J Rheumatol       Date:  2017-09-15       Impact factor: 4.666

2.  Faecal microbiome in new-onset juvenile idiopathic arthritis.

Authors:  M V Tejesvi; M Arvonen; S M Kangas; P L Keskitalo; A M Pirttilä; T J Karttunen; P Vähäsalo
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2015-12-30       Impact factor: 3.267

Review 3.  Gut inflammation and microbiome in spondyloarthritis.

Authors:  Jayakanthan Kabeerdoss; Pulukool Sandhya; Debashish Danda
Journal:  Rheumatol Int       Date:  2015-12-30       Impact factor: 2.631

4.  Effect of probiotics on clinical and immune parameters in enthesitis-related arthritis category of juvenile idiopathic arthritis.

Authors:  A Shukla; P Gaur; A Aggarwal
Journal:  Clin Exp Immunol       Date:  2016-09       Impact factor: 4.330

5.  Gastrointestinal issues in children with rheumatologic disease.

Authors:  Mirna Chehade; Keith Benkov
Journal:  Curr Rheumatol Rep       Date:  2002-12       Impact factor: 4.592

6.  Altered expression of intestinal human leucocyte antigen D-related and immune signalling molecules in juvenile idiopathic arthritis.

Authors:  M Arvonen; P Vähäsalo; S Turunen; H M Salo; M Mäki; K Laurila; O Vaarala; T J Karttunen
Journal:  Clin Exp Immunol       Date:  2012-12       Impact factor: 4.330

Review 7.  On the pathogenesis of insulin-dependent diabetes mellitus: the role of microbiota.

Authors:  Elena Gianchecchi; Alessandra Fierabracci
Journal:  Immunol Res       Date:  2017-02       Impact factor: 2.829

Review 8.  The microbiota in pediatric rheumatic disease: epiphenomenon or therapeutic target?

Authors:  Matthew L Stoll; Randy Q Cron
Journal:  Curr Opin Rheumatol       Date:  2016-09       Impact factor: 5.006

Review 9.  Non-invasive investigation in patients with inflammatory joint disease.

Authors:  Elisabetta Dal Pont; Renata D'Incà; Antonino Caruso; Giacomo-Carlo Sturniolo
Journal:  World J Gastroenterol       Date:  2009-05-28       Impact factor: 5.742

10.  The Development of Extra-Articular Manifestations in Children With Enthesitis-Related Arthritis: Natural Course or Different Disease Entity?

Authors:  Ilaria Pagnini; Mariangela Scavone; Ilaria Maccora; Maria Vincenza Mastrolia; Edoardo Marrani; Federico Bertini; Lovro Lamot; Gabriele Simonini
Journal:  Front Med (Lausanne)       Date:  2021-05-13
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.